Gao et al. (31) reported that, in the tumor microenvironment, TGF-β can induce the conversion of mouse NK cells to an NK-ILC1 intermediate cell type (intILC1s) and, finally, to ILC1s; the switch is accompanied by the down-regulation of the transcription factor Eomes. This evidence concerns the gene TGFB1 and neoplasm.